首页> 外文期刊>International immunopharmacology >Mangiferin antagonizes TNF-alpha-mediated inflammatory reaction and protects against dermatitis in a mice model
【24h】

Mangiferin antagonizes TNF-alpha-mediated inflammatory reaction and protects against dermatitis in a mice model

机译:Mangiferin拮抗TNF-α-介导的炎症反应,并在小鼠模型中保护皮炎

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study aimed to investigate whether mangiferin played a protective role in a well-established dermatitis mouse model and tumor necrosis factor alpha (TNF-alpha)-induced RAW264.7 macrophages. Contact dermatitis is an inflammatory skin disease in the clinic, while its underlying mechanism still remains to be elucidated. Mangiferin, 1,3,6,7-tetrahydroxyxanthone-C2-beta-D-glucoside (C-glucosyl xanthone), a natural antioxidant that was reported to inhibit inflammatory reactions, has been recently proved to be a potential therapy for inflammation. As a result, the oxazolone-induced dermatitis mice models were established to explore whether mangiferin has an anti-inflammatory role in vivo. The phosphate-buffered saline treatment groups showed emblematic skin inflammation, whereas the administration of mangiferin obviously inhibited dermatitis in the mice models. Furthermore, exogenous mangiferin alleviated the inflammatory reaction in TNF-alpha-induced macrophages by suppressing the production of inflammation- and oxidative stress associated molecules. Also, mangiferin treatment repressed the activation of nuclear factor-kappaB signaling pathway. To sum up, mangiferin could provide a new target for the therapy and prevention of skin inflammation. (C) 2017 Elsevier B.V. All rights reserved.
机译:本研究旨在调查Mangiferin是否在良好的皮炎小鼠模型和肿瘤坏死因子α(TNF-α)中发挥了保护作用 - 诱导的Raw264.7巨噬细胞。接触性皮炎是诊所的炎症皮肤病,而其潜在的机制仍然仍有待阐明。 Mangiferin,1,3,6,7-四羟基吡啶酮-C2-β-D-葡萄糖苷(C-葡糖糖苷),据证明据证明是抑制炎症反应的天然抗氧化剂,是炎症的潜在疗法。结果,建立了恶唑酮诱导的皮炎小鼠模型,以探索Mangiferin是否在体内具有抗炎作用。磷酸盐缓冲的盐水处理基团显示出象征性皮肤炎症,而Mangiferin的给药明显抑制小鼠模型中的皮炎。此外,外源性Mangiferin通过抑制炎症和氧化应激相关分子的产生来减轻TNF-α-诱导的巨噬细胞中的炎症反应。此外,Mangiferin治疗抑制了核因子 - κB信号传导途径的激活。总而言之,Mangiferin可以为治疗和预防皮肤炎症提供新的靶标。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号